After more than six hours of deliberation, a Philadelphia jury unanimously returned a defense verdict Wednesday in a lawsuit alleging that a hormone replacement therapy drug caused breast cancer in an Indiana woman who died of the disease. The verdict in favor of drugmaker Wyeth came because the jury found a lack of factual causation of Cheryl Foust's disease by her use of the HRT drug Prempro. The defense in the case, however, did not get all of the answers it wanted on the questions presented to the jury.
Philadelphia Jury Finds for Wyeth in Hormone Replacement Therapy Case
The Legal Intelligencer
February 25, 2010